Caption Management, LLC Aerie Pharmaceuticals Inc Call Options Transaction History

Caption Management, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2021 Feb 11, 2022	SELL	$7.02 - $13.33 $256,931 - $487,878	-36,600 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$11.32 - $16.63 $1.85 Million - $2.72 Million	-163,400 Reduced 81.7%	36,600 $417,000
Q4 2019 Feb 13, 2020	BUY	$17.72 - $25.1 $1.33 Million - $1.88 Million	75,000 Added 60.0%	200,000 $4.83 Million
Q3 2019 Nov 14, 2019	BUY	$18.41 - $28.0 $2.3 Million - $3.5 Million	125,000 New	125,000 $2.4 Million

2.4M

Ticker AERI
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,390,500
Description
Aerie Pharmaceuticals, Inc., a pharmaceutical company, focuses on the discovery, development, and commercialization of ophthalmic therapies for open-angle glaucoma, dry eye, diabetic macular edema, and wet age-related macular degeneration in the United States. Its products include Rhopressa, a once-daily eye drop to reduce elevated intraocular p...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.